Peter Kolchinsky
Sits on 26 boards. Overboarded · 26 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 26
- Current seats
- 26
- Board service
- 64 years
- Director since
- 2023
64 years of board service in total across 26 boards, counting each seat separately. Longest: Werewolf Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Wave Life Sciences Inc. August 5, 202599.7%
-
ARS Pharmaceuticals Inc. June 25, 202582.2%
-
Wave Life Sciences Inc. August 6, 202499.7%
-
Wave Life Sciences Inc. August 1, 202399.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 23, 2026 | Artiva Biotherapeutics Inc. | Open-market purchase | +59,880 | $9.96 | $596,405 |
| Jul 22, 2026 | Artiva Biotherapeutics Inc. | Open-market purchase | +84,124 | $9.93 | $835,351 |
| Jul 21, 2026 | Artiva Biotherapeutics Inc. | Open-market purchase | +120,582 | $9.55 | $1,151,558 |
| Jun 16, 2026 | Artiva Biotherapeutics Inc. | Open-market purchase | +124,893 | $8.89 | $1,110,299 |
| Jun 15, 2026 | Artiva Biotherapeutics Inc. | Open-market purchase | +15,414 | $8.99 | $138,572 |
| Jun 12, 2026 | Artiva Biotherapeutics Inc. | Open-market purchase | +391,019 | $8.57 | $3,351,033 |
| Jun 11, 2026 | Werewolf Therapeutics Inc. | Open-market sale | −245,066 | $0.38 | $93,125 |
| Jun 11, 2026 | Werewolf Therapeutics Inc. | Open-market sale | −17,437 | $0.38 | $6,626 |
| Jun 10, 2026 | Werewolf Therapeutics Inc. | Open-market sale | −42,872 | $0.37 | $15,863 |
| Jun 10, 2026 | Werewolf Therapeutics Inc. | Open-market sale | −3,051 | $0.37 | $1,129 |
| Jun 9, 2026 | Werewolf Therapeutics Inc. | Open-market sale | −345,235 | $0.37 | $127,737 |
| Jun 9, 2026 | Werewolf Therapeutics Inc. | Open-market sale | −24,565 | $0.37 | $9,089 |
| May 12, 2026 | Hemab Therapeutics Holdings Inc. | Open-market purchase | +6,387 | $24.90 | $159,036 |
| Apr 6, 2026 | Vor Biopharma Inc. | Open-market sale | −537,754 | $16.51 | $8,878,319 |
| Apr 6, 2026 | Vor Biopharma Inc. | Open-market sale | −44,728 | $17.31 | $774,242 |
Questions about Peter Kolchinsky
What boards is Peter Kolchinsky on?
Peter Kolchinsky sits on the boards of ARS Pharmaceuticals Inc., Acrivon Therapeutics Inc., Acumen Pharmaceuticals Inc., Artiva Biotherapeutics Inc., Bambusa Therapeutics Inc., Bicara Therapeutics Inc., Black Diamond Therapeutics Inc., Climb Bio Inc., Evommune Inc., Freenome Inc. and 16 others.
How long has Peter Kolchinsky served on boards?
Our records show at least 64 years of board service across 26 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.